[1] LANE JM, RUSSELL L, KHAN SN. Osteoporosis. Clin Orthop Relat Res. 2000;(372): 139-150.
[2] YU B, WANG CY. Osteoporosis: The result of an ‘Aged’ bone microenvironment. Trends Mol Med. 2016;22(8):641-644.
[3] GREWE JM, KNAPSTEIN PR, DONAT A, et al. The role of sphingosine-1-phosphate in bone remodeling and osteoporosis. Bone Res. 2022;10(1):34.
[4] COMPSTON JE, MCCLUNG MR, LESLIE WD. Osteoporosis. Lancet. 2019; 393(10169):364-376.
[5] SONG S, GUO Y, YANG Y, et al. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Therapeut. 2022;237:108168.
[6] EASTELL R, O’NEILL TW, HOFBAUER LC, et al. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016;2(1):16069.
[7] MANOLAGAS SC. From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis. Endocr Rev. 2010;31(3):266-300.
[8] ENSRUD KE. Bisphosphonates for Postmenopausal Osteoporosis. JAMA. 2021; 325(1):96.
[9] BOLOGNESE MA. SERMs and SERMs with estrogen for postmenopausal osteoporosis. Rev Endocr Metab Dis. 2010;11(4):253-259.
[10] RUSSELL RG, WATTS NB, EBETINO FH, et al. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008;19(6):733-759.
[11] FUGGLE N, AL-DAGHRI N, BOCK O, et al. Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging Clin Exp Res. 2022; 34(11):2625-2634.
[12] WOTTON CJ, GREEN J, BROWN A, et al. Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women. Bone. 2019;124:69-74.
[13] OKUMURA N, ITO T, DEGAWA T, et al. Royal jelly protects against epidermal stress through upregulation of the NQO1 expression. Int J Mol Sci. 2021;22(23):12973.
[14] WANG J, ZHANG W, ZOU H, et al. 10-Hydroxy-2-decenoic acid inhibiting the proliferation of fibroblast-like synoviocytes by PI3K-AKT pathway. Int Immunopharmacol. 2015;28(1):97-104.
[15] YOU M, MIAO Z, TIAN J, et al. Trans-10-hydroxy-2-decenoic acid protects against LPS-induced neuroinflammation through FOXO1-mediated activation of autophagy. Eur J Nutr. 2020;59(7):2875-2892.
[16] SHIRAKAWA T, MIYAWAKI A, MATSUBARA T, et al. Daily oral administration of protease-treated royal jelly protects against denervation-induced skeletal muscle atrophy. Nutrients. 2020;12(10):3089.
[17] GAO K, SU B, DAI J, et al. Anti-biofilm and anti-hemolysis activities of 10-Hydroxy-2-decenoic acid against staphylococcus aureus. Molecules. 2022;27(5):1485.
[18] RUOLAN W, LIANGJIAO C, LONGQUAN S. The mTOR/ULK1 signaling pathway mediates the autophagy-promoting and osteogenic effects of dicalcium silicate nanoparticles. J Nanobiotechnol. 2020;18(1):119.
[19] WANG J, YI Z, JIN C, et al. The role of autophagy in bone metabolism and clinical significance. Autophagy. 2023;19(9):2409-2427.
[20] AMBROGINI E, ALMEIDA M, MARTIN-MILLAN M, et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 2010;11(2):136-146.
[21] TSAY J, YANG Z, ROSS FP, et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood. 2010;116(14):2582-2589.
[22] TIAN B, LI X, ZHANG J, et al. A 3D-printed molybdenum-containing scaffold exerts dual pro-osteogenic and anti-osteoclastogenic effects to facilitate alveolar bone repair. Int J Oral Sci. 2022;14(1):45.
[23] XU C, WANG L, FOZOUNI P, et al. SIRT1 is downregulated by autophagy in senescence and ageing. Nat Cell Biol. 2020;22(10):1170-1179.
[24] YANG K, VELAGAPUDI S, AKHMEDOV A, et al. Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress. Cardiovasc Res. 2023;119(12):2190-2201.
[25] RACHED MT, KODE A, XU L, et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 2010;11(2):147-160.
[26] CHANG Y. The comparison study of using density gradient media in isolation of marrow derived human mesenchymal stem cells. Bone. 2009;44:S322-S323.
[27] PURWANINGRUM M, JAMILAH NS, PURBANTORO SD, et al. Comparative characteristic study from bone marrow-derived mesenchymal stem cells. J Vet Sci. 2021;22(6):e74.
[28] ZHANG X, GONCALVES R, MOSSER DM. The isolation and characterization of murine macrophages. Curr Protoc Immunol. 2008;83(1):14.1.1-14.1.14.
[29] BOYLE WJ, SIMONET WS, LACEY DL. Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-342.
[30] LIANG C, XING H, WANG C, et al. Resveratrol protection against IL-1β-induced chondrocyte damage via the SIRT1/FOXO1 signaling pathway. J Orthop Surg Res. 2022;17(1):406.
[31] ZOU J, CHEN H, FAN X, et al. Garcinol prevents oxidative stress-induced bone loss and dysfunction of BMSCs through NRF2-antioxidant signaling. Cell Death Discov. 2024;10(1):82.
[32] LISTENBERGER LL, HAN X, LEWIS SE, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci. 2003;100(6):3077-3082.
[33] YIN Y, TIAN BM, LI X, et al. Gold nanoparticles targeting the autophagy–lysosome system to combat the inflammation-compromised osteogenic potential of periodontal ligament stem cells: From mechanism to therapy. Biomaterials. 2022;288:121743.
[34] HU R, LUO H, JI Y, et al. Activation of NLRP3 signaling contributes to cadmium-induced bone defects, associated with autophagic flux obstruction. Sci Total Environ. 2023;893:164787.
[35] YANG Q, ZHOU Y, WANG T, et al. MiRNA-1271-5p regulates osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting forkhead box O1 (FOXO1). Cell Biol Int. 2021;45(7):1468-1476.
[36] FENG YL, JIANG XT, MA FF, et al. Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity. Int J Mol Med. 2018;41(1):202-212.
[37] LIU J, BAO X, HUANG J, et al. TMEM135 maintains the equilibrium of osteogenesis and adipogenesis by regulating mitochondrial dynamics. Metabolism. 2024;152: 155767.
[38] BAI J, WANG H, CHEN H, et al. Biomimetic osteogenic peptide with mussel adhesion and osteoimmunomodulatory functions to ameliorate interfacial osseointegration under chronic inflammation. Biomaterials. 2020;255:120197.
[39] CHURCHMAN SM, BOXALL SA, MCGONAGLE D, et al. A4.08 Predicting senescence-related loss of MSC osteogenic capacity irrespective of donor age. Ann Rheum Dis. 2016;75:A40.
[40] YU Y, SHEN X, LUO Z, et al. Osteogenesis potential of different titania nanotubes in oxidative stress microenvironment. Biomaterials. 2018;167:44-57.
[41] CHEN Y, ZHOU F, LIU H, et al. SIRT1, a promising regulator of bone homeostasis. Life Sci. 2021;269:119041.
[42] YU X, CHEN X, WU W, et al. Zinc Alleviates diabetic muscle atrophy via modulation of the SIRT1/FoxO1 autophagy pathway through GPR39. J Cachexia Sarcopeni. 2025;16(2):e13771.
[43] RUAN Y, XUE Y, ZHANG P, et al. Acetylation of FOXO1 is involved in cadmium-induced rat kidney injury via mediating autophagosome-lysosome fusion blockade and autophagy inhibition. Ecotox Environ Safe. 2024;287:117253.
[44] LI H, DANHUI L, ZHENGMIN M, et al. Defective autophagy in osteoblasts induces endoplasmic reticulum stress and causes remarkable bone loss. Autophagy. 2018;14(10):1726-1741.
[45] YOSHIDA G, TSUYOSHI K, HYOTA T, et al. Degradation of the NOTCH intracellular domain by elevated autophagy in osteoblasts promotes osteoblast differentiation and alleviates osteoporosis. Autophagy. 2022;18(10):2323-2332.
[46] ZHANG Y, LIU W, YUAN W, et al. Impairment of APPL1/Myoferlin facilitates adipogenic differentiation of mesenchymal stem cells by blocking autophagy flux in osteoporosis. Cell Mol Life Sci. 2022;79(9):488.
[47] ZHAN W, DENG M, HUANG X, et al. Pueraria lobata-derived exosome-like nanovesicles alleviate osteoporosis by enhacning autophagy. J Control Release. 2023;364:644-653.
[48] ABDULLAH KS, ALHAMDANY DA. AB0811 Total antioxidant status and oxidative stress in patients with osteopenia and osteoporosis. Ann Rheum Dis. 2014;73:1071.
[49] PENG J, LIU R, XU J, et al. Acid-responsive aggregated carrot-derived nanoantioxidants alleviate oxidative stress and restore osteoblast activity. J Nanobiotechnol. 2025;23(1):206.
[50] COMAS F, LATORRE J, ORTEGA F, et al. Permanent cystathionine-β-Synthase gene knockdown promotes inflammation and oxidative stress in immortalized human adipose-derived mesenchymal stem cells, enhancing their adipogenic capacity. Redox Biology. 2021;42:101668.
[51] KANZAKI H, SHINOHARA F, KANAKO I, et al. Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes. Redox Biol. 2016;8: 186-191.
[52] EFFRAIMIDIS G, WATT T, FELDT-RASMUSSEN U. Levothyroxine therapy in elderly patients with hypothyroidism. Front Endocrinol. 2021;12:641560.
[53] MEUNIER PJ, ROUX C, SEEMAN E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. New Engl J Med. 2004;350(5):459-468.
[54] LIU F, WANG X, HE Y, et al. Jaw osteoporosis: Challenges to oral health and emerging perspectives of treatment. Biomed Pharmacother. 2024;177:116995.
[55] MURPHY SJ, MCCULLOUGH LD, LITTLETON-KEARNEY MT, et al. Estrogen and selective estrogen receptor modulators. Endocrine. 2003;21(1):17-26.
[56] FUGGLE NR, COOPER C, HARVEY NC, et al. Assessment of cardiovascular safety of anti-osteoporosis drugs. Drugs. 2020;80(15):1537-1352.
|